Overview
- 4 public-safe observations are available for this inspection.
- 4 structured CFR citations are represented.
- 2 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
5 Oct 2021
21 CFR 211.198(a)
Complaints reviewed by Quality Control Unit
Cited by Sony Mathews, Rachael O Oyewole
5 Oct 2021
21 CFR 211.22(a)
Contract drug products--lack of responsibility
Cited by Sony Mathews, Rachael O Oyewole
5 Oct 2021
21 CFR 211.22(d)
Procedures not in writing, fully followed
Cited by Sony Mathews, Rachael O Oyewole
Inspected site
GIGreenbrier International, IncChesapeake, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
Source document
PDF
PDF available
Form 483 source document
The source document is available to authorized Atlas users.
Full 483 report
Get the verbatim text of all 4 observations
The source PDF, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere